KSC 2020 | 64th Annual Scientific Meeting of The Korean Society of Cardiology

일정표

Symposium
Intervention 1
Which Evidence-Based NOAC Should Be the Preferred Dual Anti-thrombotic Regimen in AF Patients Undergoing PCI?
Oct. 16 (Fri.) 17:20-18:50, Channel 04

17:20 - 17:35

P2Y12 Inhibitor with Rivaroxaban

[Speaker] 박경우/서울의대

17:35 - 17:50

P2Y12 Inhibitor with Dabigatran

[Speaker] 서석민/가톨릭의대

17:50 - 18:05

P2Y12 Inhibitor with Apixaban

[Speaker] 임홍석/아주의대

18:05 - 18:20

P2Y12 Inhibitor with Edoxaban

[Speaker] 박재형/고려의대

18:20 - 18:50

Discussion